| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 28, 2022 |
| Accession Number: | 0001104659-22-008582 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 28, 2022 |
| Accession Number: | 0001104659-22-008582 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
On Monday, 8 stocks made new 52-week highs. Noteworthy Points From Today's 52-Week Highs: British American Tobacco (NYSE:BTI) was the largest firm by market cap to set a new 52-week high. The smallest company when looking at market cap to set a new 52-week high was McLaren Technology (NASDAQ:MLAI). Dave (NASDAQ:DAVE) saw the most pronounced positive move, as it traded up 12.94% to hit its new 52-week high. Nicolet Bankshares (NASDAQ:NCBS)'s stock actually fell; It moved 0.52% shortly after reaching a new 52-week high. Also check out these big insider trades here Stocks that set new 52-week highs during the first half-hour of trading on Monday are as follows: British Americ
New Frontier Health Corporation (NYSE:NFH) (“NFH” or the “Company”), the operator of the premium healthcare services provider United Family Healthcare, today reported that, on January 4, 2022, the Company received a notice from the New York Stock Exchange (the “NYSE”) Regulation stating that it is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria pursuant to Section 802.01E of the NYSE Listed Company Manual (the “Continued Listing Criteria”) as a result of the Company’s failure to timely file its semi-annual financial information for the half year ended June 30, 2021 on a Current Report on Form 6-K (the “1H 2021 6-K”) with the SEC. The NYSE in
New Frontier Health Corporation (“NFH” or the “Company”) (NYSE:NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary general meeting (the “EGM”) held today, the Company’s shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of August 4, 2021 (the “Merger Agreement”), among the Company, Unicorn II Holdings Limited (“HoldCo”), Unicorn II Parent Limited (“Parent”) and Unicorn II Merger Sub Limited (“Merger Sub”), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becom
BEIJING--(BUSINESS WIRE)--New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that its board of directors (the “Board”) has formed a special committee (the “Special Committee”) consisting of three independent directors, Dr. Edward Leong Che-hung, Professor Frederick Ma Si-hang and Mr. Lawrence Chia, to review and evaluate the previously announced preliminary non-binding “going private” proposal (the “Proposal”) set out in a letter dated February 9, 2021 from a buyer group consisting of New Frontier Public Holding Ltd. (“NFPH”), Carnival Investments Limited, a company affi
15-12B - New Frontier Health Corp (0001737422) (Filer)
EFFECT - New Frontier Health Corp (0001737422) (Filer)
POS AM - New Frontier Health Corp (0001737422) (Filer)
Credit Suisse downgraded New Frontier Health from Outperform to Neutral and set a new price target of $12.00
SC 13D/A - New Frontier Health Corp (0001737422) (Subject)
SC 13D/A - New Frontier Health Corp (0001737422) (Subject)
SC 13D/A - New Frontier Health Corp (0001737422) (Subject)
New Frontier Health Corporation ("NFH" or the "Company") (NYSE:NFH), operator of the premium healthcare services provider United Family Healthcare, today announced the completion of its merger (the "Merger") with Unicorn II Merger Sub Limited ("Merger Sub"), pursuant to the previously announced agreement and plan of merger, dated as of August 4, 2021 (the "Merger Agreement"), among the Company, Unicorn II Holdings Limited ("HoldCo"), Unicorn II Parent Limited ("Parent") and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company. Pursuant to the terms of the Merger Agreement, which was approved by the Comp
New Frontier Health Corporation (NYSE:NFH) ("NFH" or the "Company"), the operator of the premium healthcare services provider United Family Healthcare, today reported that, on January 4, 2022, the Company received a notice from the New York Stock Exchange (the "NYSE") Regulation stating that it is not in compliance with the NYSE's continued listing requirements under the timely filing criteria pursuant to Section 802.01E of the NYSE Listed Company Manual (the "Continued Listing Criteria") as a result of the Company's failure to timely file its semi-annual financial information for the half year ended June 30, 2021 on a Current Report on Form 6-K (the "1H 2021 6-K") with the SEC. The NYSE i
New Frontier Health Corporation ("NFH" or the "Company") (NYSE:NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary general meeting (the "EGM") held today, the Company's shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of August 4, 2021 (the "Merger Agreement"), among the Company, Unicorn II Holdings Limited ("HoldCo"), Unicorn II Parent Limited ("Parent") and Unicorn II Merger Sub Limited ("Merger Sub"), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and beco
BEIJING--(BUSINESS WIRE)--New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare ("UFH"), today announced its financial results for the fourth quarter and fiscal year ended December 31, 2020. Financial and Operating Highlights1 All comparisons made on both a year-over-year (“yoy”) and quarter-on-quarter (“qoq”) basis. 2 For the Quarter Ended December 31, 2020: Revenue increased by 2.2% yoy to RMB654.0 million from RMB639.7 million and increased by 4.4% from the prior quarter, as patient volume recovered from the COVID-19 pandemic onset. Net loss decreased to RMB101.4 million from RMB2